Deep Brain Stimulation Devices Market Worth $2.3 Billion By 2028
The global Deep Brain Stimulation Devices Market size is anticipated to reach USD 2.3 billion by 2028, according to
a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.3% from 2021 to 2028.
Surge in incidence of neurological disorders, growing awareness about the deep brain stimulation devices and
introduction of technologically advanced productsis attributing to the growth of market.
The incidence of neurological disorders such as Parkinson's disease, epilepsy, and depression is increasing globally,
which is anticipated to positively impact the market growth. For instance, according to Depression and Bipolar
Support Alliance, around 17.3 million adults in the U.S. are suffering from major depressive disorder. Thus, large
number of people suffering from such conditions and disorders is expected to boost market growth during the
Potential benefits of Deep Brain Stimulation (DBS) devices such as long-term benefits and better postoperative
outcomes, are anticipated to fuel the market growth. Additionally, these advancements help clinical researchers in
investigational efficacy studies for the inclusion of DBS devices in the treatment of other neurological disorders.
Such factors are expected to raise the demand for DBS devices over the forecast period.
Related Press Release @ Deep Brain Stimulation Devices Market Report
Deep Brain Stimulation Devices Market Report Highlights
On the basis of product, the dual channel segment dominated the market in 2020 with the share of 57.2%.
Growing adoption of double-channel DBS devices for treatment of numerous neurological disorders, such
as PD, dystonia, Alzheimer’s, and epilepsy driving the segment
Based on application, the Parkinson’s disease segment dominated the market in 2020 with the share of
65.2% owing to rising prevalence of PD globally. According to UCB report, around 100,000 people in Canada
are living w